{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:29:39Z","timestamp":1783110579884,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13102-2","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:06:09Z","timestamp":1774533969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of a simplified agar-based population analysis profiling as a practical alternative for detecting heteroresistance in clinical bacterial isolates"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieying","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"1","key":"13102_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/cmr.00058-14","volume":"28","author":"OM El-Halfawy","year":"2015","unstructured":"El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev. 2015;28(1):191\u2013207. https:\/\/doi.org\/10.1128\/cmr.00058-14.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"13102_CR2","doi-asserted-by":"publisher","first-page":"e1007726","DOI":"10.1371\/journal.ppat.1007726","volume":"15","author":"VI Band","year":"2019","unstructured":"Band VI, Weiss DS. Heteroresistance: a cause of unexplained antibiotic treatment failure? PLoS Pathog. 2019;15(6):e1007726. https:\/\/doi.org\/10.1371\/journal.ppat.1007726.","journal-title":"PLoS Pathog"},{"issue":"2","key":"13102_CR3","doi-asserted-by":"publisher","first-page":"e0101021","DOI":"10.1128\/Spectrum.01010-21","volume":"9","author":"J Jo","year":"2021","unstructured":"Jo J, Ko KS. Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii. Microbiol Spectr. 2021;9(2):e0101021. https:\/\/doi.org\/10.1128\/Spectrum.01010-21.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"13102_CR4","doi-asserted-by":"publisher","first-page":"105832","DOI":"10.1016\/j.ijantimicag.2019.10.013","volume":"55","author":"X Jia","year":"2020","unstructured":"Jia X, Ma W, He J, Tian X, Liu H, Zou H, et al. Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia. Int J Antimicrob Agents. 2020;55(3):105832. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.10.013.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"13102_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41564-018-0342-0","volume":"4","author":"H Nicoloff","year":"2019","unstructured":"Nicoloff H, Hjort K, Levin BR, Andersson DI. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat Microbiol. 2019;4(3):504\u2013514. https:\/\/doi.org\/10.1038\/s41564-018-0342-0.","journal-title":"Nat Microbiol"},{"key":"13102_CR6","doi-asserted-by":"publisher","unstructured":"Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol. 2019. https:\/\/doi.org\/10.1038\/s41579-019-0218-1.","DOI":"10.1038\/s41579-019-0218-1"},{"issue":"4","key":"13102_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1128\/jcm.02302-10","volume":"49","author":"SJ van Hal","year":"2011","unstructured":"van Hal SJ, Wehrhahn MC, Barbagiannakos T, Mercer J, Chen D, Paterson DL, et al. Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates. J Clin Microbiol. 2011;49(4):1489\u20131494. https:\/\/doi.org\/10.1128\/jcm.02302-10.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"13102_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jac\/47.4.399","volume":"47","author":"M Wootton","year":"2001","unstructured":"Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother. 2001;47(4):399\u2013403. https:\/\/doi.org\/10.1093\/jac\/47.4.399.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"13102_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/jac\/dkn554","volume":"63","author":"KI Udekwu","year":"2009","unstructured":"Udekwu KI, Parrish N, Ankomah P, Baquero F, Levin BR. Functional relationship between bacterial cell density and the efficacy of antibiotics. J Antimicrob Chemother. 2009;63(4):745\u2013757. https:\/\/doi.org\/10.1093\/jac\/dkn554.","journal-title":"J Antimicrob Chemother"},{"key":"13102_CR10","unstructured":"CLSI. Evaluation of Diagnostic Tests; CLSI Guideline EP12. 3rd. Clinical and Laboratory Standards Institute; 2023."},{"key":"13102_CR11","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing. In: CLSI supplement M100. 35th ed. Clinical and Laboratory Standards Institute; 2023."},{"issue":"7","key":"13102_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41429-020-0289-2","volume":"73","author":"L Chen","year":"2020","unstructured":"Chen L, Lin J, Lu H, Zhang X, Wang C, Liu H, et al. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China. J Antibiot (Tokyo). 2020;73(7):463\u2013470. https:\/\/doi.org\/10.1038\/s41429-020-0289-2.","journal-title":"J Antibiot (Tokyo)"},{"issue":"3","key":"13102_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijantimicag.2017.10.014","volume":"51","author":"J He","year":"2018","unstructured":"He J, Jia X, Yang S, Xu X, Sun K, Li C, et al. Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections. Int J Antimicrob Agents. 2018;51(3):413\u2013421. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.10.014.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"13102_CR14","doi-asserted-by":"publisher","first-page":"1605310","DOI":"10.1038\/nmicrobiol.2016.53","volume":"1","author":"VI Band","year":"2016","unstructured":"Band VI, Crispell EK, Napier BA, Herrera CM, Tharp GK, Vavikolanu K, et al. Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nat Microbiol. 2016;1(6):1605310. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.53.","journal-title":"Nat Microbiol"},{"issue":"3","key":"13102_CR15","doi-asserted-by":"publisher","first-page":"e0018621","DOI":"10.1128\/mBio.00186-21","volume":"12","author":"R Abe","year":"2021","unstructured":"Abe R, Akeda Y, Sugawara Y, Matsumoto Y, Motooka D, Kawahara R, et al. Enhanced carbapenem resistance through multimerization of plasmids carrying carbapenemase genes. mBio. 2021;12(3):e0018621. https:\/\/doi.org\/10.1128\/mBio.00186-21.","journal-title":"mBio"},{"issue":"9092","key":"13102_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/s0140-6736(97)07324-8","volume":"350","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet (Lond, Engl). 1997;350(9092):1670\u20131673. https:\/\/doi.org\/10.1016\/s0140-6736(97)07324-8.","journal-title":"Lancet (Lond, Engl)"},{"issue":"Suppl 1","key":"13102_CR17","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1093\/cid\/cit614","volume":"58","author":"KA Rodvold","year":"2014","unstructured":"Rodvold KA, McConeghy KW. Methicillin-resistant Staphylococcus aureus therapy: past, present, and future. Clin Infect Dis. 2014;58(Suppl 1):S20\u201327. https:\/\/doi.org\/10.1093\/cid\/cit614.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"13102_CR18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/jcm.02135-08","volume":"47","author":"AC Musta","year":"2009","unstructured":"Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, et al. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. J Clin Microbiol. 2009;47(6):1640\u20131644. https:\/\/doi.org\/10.1128\/jcm.02135-08.","journal-title":"J Clin Microbiol"},{"key":"13102_CR19","doi-asserted-by":"publisher","first-page":"Cd007022","DOI":"10.1002\/14651858.CD007022.pub2","volume":"6","author":"AB Cavalcanti","year":"2010","unstructured":"Cavalcanti AB, Goncalves AR, Almeida CS, Bugano DD, Silva E. Teicoplanin versus vancomycin for proven or suspected infection. Cochrane Database Systematic Rev. 2010;6:Cd007022. https:\/\/doi.org\/10.1002\/14651858.CD007022.pub2.","journal-title":"Cochrane Database Systematic Rev"},{"issue":"10","key":"13102_CR20","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1128\/aac.01406-06","volume":"51","author":"JR Lo-Ten-Foe","year":"2007","unstructured":"Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2007;51(10):3726\u201330. https:\/\/doi.org\/10.1128\/aac.01406-06.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"13102_CR21","first-page":"269","volume":"67","author":"A Norazah","year":"2012","unstructured":"Norazah A, Law NL, Kamel AG, Salbiah N. The presence of heterogeneous vancomycin-lntermediate Staphylococcus aureus (heteroVISA) in a major Malaysian hospital. Med J Malaysia. 2012;67(3):269\u201373.","journal-title":"Med J Malaysia"},{"issue":"3","key":"13102_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.diagmicrobio.2011.06.010","volume":"71","author":"H Chen","year":"2011","unstructured":"Chen H, Liu Y, Sun W, Chen M, Wang H. The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC. Diagn Microbiol Infect Dis. 2011;71(3):301\u2013303. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.06.010.","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13102-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:39:01Z","timestamp":1778150341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13102-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13102"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13102-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8165942\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the institutional review board of the First Affiliated Hospital, Sun Yat-sen University. All patients received detailed pretest counseling and informed written consent was obtained from each participant. Our study was in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"917"}}